Author: ProfKeith

Is Alzheimers diabetes of the brain?

Is Alzheimer’s really a  type 3 diabetes of the brain? Evidence suggests it is. By which I mean that insulin and Avandia, drugs used to control diabetes somewhat successfully have a definite beneficial effect on the risk of developing Alzheimer’s. Note that is NOT the same as saying they will help Alzheimer’s, once developed. This startling new turn has been reinforced by a study published Feb 2009 in the Proceedings of the National Academy of Sciences. Researchers at Northwestern University treated nerve cells from the hippocampus, which is where we make our lasting memories. They subjected cells to insulin and the drug Avandia, which is used to treat type 2 diabetes. In doing so the researchers discovered that insulin protected the cells from clumps of toxic proteins called beta-amyloid. This structural change (amyloid plaques), along with neurofibrillary tangles, are the two definitive markers for Alzheimer’s. It is beginning to look like Alzheimer’s is actually a third type of diabetes! Dr. Sergio T. Ferreira, a member of the research team and a professor of biochemistry in Rio de Janeiro, Brazil, said in a news release,"Recognizing that Alzheimer’s disease is a type of brain diabetes points the way to novel discoveries that may finally result in disease-modifying treatments for this devastating disease." Brain cells need insulin to survive and a drop in brain insulin levels leads to brain cell damage. Memory...

Read More

Smash That Garlic!

We all know the alleged benefits of garlic.  It is supposed to protect us against cancer and heart disease, bacterial and viral infections, and do a whole host of other good things for us. I don’t think there’s even any argument any more from conventional medicine that fresh garlic is a wonderful health giving plant substance.  The odd thing however is that garlic contains very few antioxidant substances.  Exactly why it has its powerful benefits therefore remains something of a mystery. However, as I revealed in my 1993 book, Food Allergy and Environmental Illness, it does seem that the important ingredient is an organic compound called allicin.  This is the substance which gives garlic it’s highly characteristic pungent aroma.  And it does seem that if the garlic doesn’t smell, it doesn’t have any health benefits. Now scientists have taken things a step further. Derek Pratt, a chemistry professor at Queen’s University in Kingston, Ontario, Canada, and his research team have found that the decomposition of allicin produces sulfenic acid, which rapidly reacts with radicals. What the scientists have shown is that the allicin compound has to decompose in order to generate the potent antioxidant. Sulfenic acid it emerges, is one of the quickest acting antioxidants known.  Its superfast. So now you know.  Garlic, I believe is one of the reasons for the success of the Mediterranean diet.  It is...

Read More

Diet beats Alzheimers every time

Yet again diet and nutrition has come out as a major factor in the causes of development of Alzheimer’s disease.  Forget the genetic story.  It’s almost totally irrelevant.  The "familial incidence" of Alzheimer’s is almost always due to family sharing the same crummy diet habits. In any case, numerous studies have made it clear that no matter your genetic disposition, ultimately Alzheimer’s disease is turned on or off by external environmental factors, principally diet and nutrition. The latest study to make the connection, published in the archives of neurology, February 2009 (vol 66: pp 216-225), showed that the Mediterranean style diet was a great protective against mild cognitive impairment (MPI). MPI is a stage of memory loss between typical aging and Alzheimer’s disease (severe cognitive impairment). The Mediterranean diet consists of lots of fish, fruit and vegetables, legumes, a little bread, and unsaturated fatty acids; low amounts of dairy products, meat, and saturated fats; and a moderate amount of alcohol (actually wine – KSM) Participants in this particular study were recruited between 1992 and 1999; all were Medicare beneficiaries living in the northern part of Manhattan. At the start of the study, there were 1,393 participants with no cognitive impairments and 482 with mild cognitive impairment. The findings are very straightforward.  The closer the participants followed the Mediterranean diet plan, the less cognitive impairment.  In fact those who most...

Read More

More cancer markers?

Logically, you might think that counting the number of cancer cells in circulation in the blood might be a good way to measure the potential dangers of a cancer.  There are some surprising problems with this.  Dr. Ryke Geerde Hamer has pointed out that it’s very rare indeed to find cancer cells in circulation.  From that he has speculated that secondary cancers are not spread via the blood but are new cancers, that have arisen due to the shock of diagnosis. Whereas, I love and respect the work of Dr. Hamer, I disagree with him in this.  I turn instead to the model of Dr Rife, whose brilliant microscope (section 35) enabled him to see tiny sub-bacterial bodies that he likened to viruses and called the BX organism. Like Rife, I think that this is how cancer is spread to remote tissues. Rife found the BX organism in all cancer patients and was able to kill it with 100% success, using his amazing beam ray machine. Despite the scarcity of circulating cancer cells, using this phenomenon is a cancer marker is not a lost cause.  I found a recent study previewed in a cancer journal The Lancet Oncology, Feb. 10, 2009, which stated that checking for changes in the number of circulating tumor cells (CTCs) could help doctors predict advanced prostate cancer patients’ survival and response to treatment. CTC...

Read More

Too Many Chemo Drugs May Make Matters Worse

If two is good four is better; isn’t that the mentality of the orthodox medical profession?  Two aspirins don’t work; well, take four! It’s nonsense, of course. Especially in respect of chemotherapy, which is highly toxic.  Taking one drug is bad enough, taking two is pretty horrible, but there can be virtually no logical foundation for giving a patient three or four chemo drugs simultaneously.  Of course the shaky theory is that by tackling a tumour using different chemical mechanisms, we can get a better result. But that ignores the adding together of the toxic aspect of the treatment. It defies all reason that if one toxin comes close to killing the patient, three or four toxic substances are going to be no more deleterious. Yet this approach is exactly what’s been happening in a recent trial conducted in Holland; adding a fourth anti-cancer drug to a three-medication treatment actually makes things worse for people with advanced colorectal cancer. The average survival time for people in the trial who got the four-drug combination was 9.4 months, compared with 10.7 months for those given the three-medication regimen. Also, adverse drug reactions were more frequent in those given the four drugs. The study of 755 people whose colorectal cancers had spread to other parts of the body was done because not only animal studies but two smaller human trials had found...

Read More

From the Desk of Dr. Keith

Follow Us on Facebook